Evolution of the Average Target: UGI Corporation

Evolution of the Average Target - UGI Corporation

Evolution of the Target Price: UGI Corporation

Evolution of the Target Price - UGI Corporation

Changes in Analyst Recommendations: UGI Corporation

d25ee03.Bp9A9aR5wukcPkgL5D7e5RJIfqdI0SKIGJXfH042tLk.Mfw1gvcIibp9BglgkFHpv2hwC5MkoWDjYNO9SAhR_-Ar-wagiSiIpGkPCQ~d39c2fc11f72e21d31426a9aab3845f0
Sep. 29 Scotiabank Initiates UGI at Sector Outperform With $46 Price Target MT
Sep. 14 Huntington Capital Initiates UGI at Outperform With $54 Price Target MT
Sep. 09 UGI Shares Rise After Jefferies Upgrade MT
Sep. 09 Jefferies Upgrades UGI to Buy From Hold, Adjusts Price Target to $43 From $40 MT
24-11-15 Mizuho Upgrades UGI to Outperform From Neutral, Adjusts Price Target to $30 From $27 MT
24-04-17 Mizuho Raises Price Target on UGI to $27 From $26, Keeps Neutral Rating MT
24-03-14 Wells Fargo Downgrades UGI to Equalweight From Overweight, Adjusts Price Target to $28 From $27 MT
24-01-18 Mizuho Adjusts UGI's Price Target to $26 From $29, Keeps Neutral Rating MT
23-09-11 Mizuho Securities Adjusts UGI Price Target to $29 From $33, Maintains Neutral Rating MT
23-08-28 Wells Fargo Upgrades UGI to Overweight From Equalweight, Trims Price Target to $27 From $28 MT
23-08-04 Wells Fargo Adjusts Price Target on UGI to $28 From $35, Maintains Equal-Weight Rating MT
23-04-18 Barclays Adjusts Price Target on UGI to $37 From $40, Maintains Underweight Rating MT
23-02-02 Barclays Adjusts Price Target on UGI to $40 From $39, Maintains Underweight Rating MT
23-01-18 Barclays Downgrades UGI to Underweight From Equalweight, Price Target is $39 MT
23-01-18 Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Oracle... Zonebourse
23-01-10 Wells Fargo Adjusts Price Target on UGI to $42 From $41, Maintains Equal-Weight Rating MT
22-11-23 BofA Securities Downgrades UGI to Underperform From Neutral, Adjusts Price Target to $41 From $43 MT
22-11-21 Wells Fargo Adjusts Price Target on UGI to $39 From $36, Maintains Equal-Weight Rating MT
22-10-19 Barclays Trims UGI's Price Target to $36 From $40, Maintains Equalweight Rating MT
22-10-19 Wells Fargo Adjusts UGI's Price Target to $36 From $42, Reiterates Equalweight Rating MT
22-10-19 Barclays Adjusts UGI's Price Target to $36 From $40, Keeps Equalweight Rating MT
22-08-08 Wells Fargo Raises UGI's Price Target to $42 From $41, Maintains Equalweight Rating MT
22-04-29 Wells Fargo Adjusts UGI's Price Target to $40 from $46, Keeps Equalweight Rating MT
22-04-27 Janney Lowers Fair Value on UGI to $60 From $64, Maintains Buy Rating MT
22-03-22 Barclays Adjusts UGI's Price Target to $40 From $45, Keeps Equalweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+12.32%
+4.47%
+9.24%
- -1.65%
+10.21%
-13.04%
+16.98%
+18.44%
Average +7.12%
Weighted average by Cap. +6.30%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
38.73USD
Average target price
43.50USD
Spread / Average Target
+12.32%
High Price Target
46.00USD
Spread / Highest target
+18.77%
Low Price Target
42.00USD
Spread / Lowest Target
+8.44%

Analyst Consensus Detail

Analyst consensus - UGI Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - UGI Corporation
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
MarketScreener Ratings - UGI Corporation
  1. Stock Market
  2. Stocks
  3. UGI Stock
  4. Consensus UGI Corporation